📰

Market News Digest — 31st Aug 2026: Pharma gains, rupee rallies, housing finance beckons

Domestic equities buoyed by pharma strength and currency support; global headwinds persist amid geopolitical tensions.

News Digest 31 Aug 2026
🗞️ Headlines🏛️ Macro & RBI📅 Earnings & Events⚡ What's Moving

Market Digest: Pharma Strength & Currency Tailwinds 📈

Indian equities kicked off the week on a constructive note, with domestic flows and central bank support underpinning sentiment. The rupee touched its strongest level in nearly a month, buoyed by equity-related inflows and RBI backing, while notching a monthly gain. Offshore headwinds remain, however, as geopolitical tensions between the US and Iran lifted crude prices and bond yields globally, weighing on European bourses.

  • 🏥 Pharma: A pharmaceutical major gained ground after its subsidiary launched a generic version of a well-known respiratory therapy in the US market, extending gains for the year-to-date period.
  • 💰 Affordable Housing Finance: A domestic research house initiated coverage on five housing finance names with constructive medium-term outlooks, citing meaningful upside scope across the cohort.
  • 💼 Smallcap Positioning: Foreign investors have been accumulating stakes in a baker's dozen of smaller-cap names during the quarter, with several rallying sharply from those entry levels.
  • 🌏 Global Markets: Asian equities faced mixed fortunes—China and Hong Kong slipped as economic data disappointed and property-sector headwinds persisted, while US policymakers signalled confidence in underlying growth momentum despite bond market volatility.

For live tracking of market developments and detailed analysis, visit momentumiq.in.

MomentumIQ
See what the screener is flagging today

⚠ For educational purposes only. Not investment advice. Historical backtests do not guarantee future performance.

Run Free Backtest Now

We use cookies to keep you signed in and understand how the platform is used. See our Privacy Policy.

Still there?

Here's something you might like

or

One email a week. No spam, unsubscribe anytime.

SEBI Compliance Disclaimer

MomentumIQ is an educational platform for strategy research and backtesting. We do not provide investment advice, recommendations, or tips. All backtest results are hypothetical, based on historical data, and for educational purposes only. Past performance is not indicative of future results. Backtested results may not account for brokerage, slippage, taxes, or other real-world costs. Please consult a SEBI-registered investment advisor before making any investment decisions.